Neutrophils promote the malignant glioma phenotype through S100A4.
about
CD8 T Cell-Independent Antitumor Response and Its Potential for Treatment of Malignant GliomasToward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ RegimenExpression Analysis of All Protease Genes Reveals Cathepsin K to Be Overexpressed in GlioblastomaContribution of the Microenvironmental Niche to Glioblastoma Heterogeneity.Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastomaInitial evidence that blood-borne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patients.Glioblastoma: Defining Tumor Niches.Decrease of VEGF-A in myeloid cells attenuates glioma progression and prolongs survival in an experimental glioma modelPeriostin (POSTN) Regulates Tumor Resistance to Antiangiogenic Therapy in Glioma Models.S100 protein family in human cancer.Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma.Resistance to antiangiogenic therapy.S100A4 hypomethylation affects epithelial-mesenchymal transition partially induced by LMP2A in nasopharyngeal carcinoma.A novel prognostic index-neutrophil times γ-glutamyl transpeptidase to lymphocyte ratio (NγLR) predicts outcome for patients with hepatocellular carcinomaActivation of CECR1 in M2-like TAMs promotes paracrine stimulation-mediated glial tumor progression.Blood-brain barrier pericyte importance in malignant gliomas: what we can learn from stroke and Alzheimer's disease.CCAAT/enhancer binding protein β induces motility and invasion of glioblastoma cells through transcriptional regulation of the calcium binding protein S100A4.The Sabotaging Role of Myeloid Cells in Anti-Angiogenic Therapy: Coordination of Angiogenesis and Immune Suppression by Hypoxia.The Microenvironmental Landscape of Brain Tumors.Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival.Tumor angiogenesis revisited: Regulators and clinical implications.Inhibitory effects of S100A4 gene silencing on alkali burn-induced corneal neovascularization: an in vivo study.Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents.Neutrophils in Gliomas.Acquired tumor resistance to antiangiogenic therapy: Mechanisms at a glance.Sex-dependent association of preoperative hematologic markers with glioma grade and progression.Screening critical genes associated with malignant glioma using bioinformatics analysis.Cell-autonomous and non-autonomous functions of S100A4 in regulating stemness, mesenchymal transition, and metastasis.S100A4 promotes lung tumor development through β-catenin pathway-mediated autophagy inhibition.Epithelial-mesenchymal transition and inflammation at the site of the primary tumor.S100A4 blockage alleviates agonistic anti-CD137 antibody-induced liver pathology without disruption of antitumor immunity.Trends in Malignant Glioma Monoclonal Antibody Therapy.Macrophages, Neutrophils, and Cancer: A Double Edged SwordNF-κB, Mesenchymal Differentiation and GlioblastomaPreoperative Changes in Hematological Markers and Predictors of Glioma Grade and Survival
P2860
Q26740520-54FC3F97-12C7-472F-A403-C994A5BBE934Q26749972-7BB89AD4-0F0F-4A67-BC73-CEB4E6EAE3A0Q29302290-991C5B78-6271-4385-AEA5-D6E535AAE9B2Q33786677-09614B17-A7DB-45DA-9895-DEA2C3045EF3Q35765180-46BF152E-B6B2-4D68-981D-501AF87F6143Q36665167-3590FCDC-1B29-40B3-B803-08F73CD76500Q36796616-0AF2B6AD-D8F4-4A96-8401-636B7EBE783FQ36977700-D136B969-ECDA-4E5D-B3A9-1C728A02D431Q37407395-93F581C5-A005-49B0-9D7D-65711B9B20D9Q37650123-67E1ED44-0540-4740-9AA1-C50197E6DD5BQ37688643-54A2ACF3-68C9-4478-8811-2E10DE78557AQ38197943-9EAF6EA5-7A8E-4A08-BF0A-3E390B52DB9EQ38296971-357571EA-066D-4989-B628-4A562C70ED7BQ38611103-39EA664C-F94D-4938-B2CA-97D5F3EAE5DDQ38705689-EDA3011B-CFE9-4827-8E65-B4B9407CEC44Q38765529-9E083A85-B534-4BDC-A03E-9100655668D2Q38903777-EAE75D6D-137B-4B27-9046-EC1956C48E08Q39034031-A07B02F5-75FA-4A81-BC16-E6943FB98CF6Q39178065-3873991C-37C0-4E5B-851B-99DF55D772D7Q39195033-AD6AC00F-6DA4-4588-8EC2-330486A5E19EQ39393740-54A931E6-A816-4102-B2D5-3F06E0535A05Q40223078-8AE311F7-39AC-43BC-9AFC-40174FAA3122Q40800162-3890A5C9-7B64-4D28-8AE6-37220E17C69AQ43749590-859EDE32-6CB6-4F2B-B313-CC619C833057Q47098476-02565BFA-F732-4827-8CF1-7336C53A9C49Q47562272-295C3F23-ED17-489A-972B-08CBC3A9C7E8Q47811682-04DAEF00-0E3E-4371-840F-545CAF0088E1Q47854911-0D06A17E-04CC-4A4A-BE3F-4947D4F178F2Q49959205-C1CD0BB8-91BF-438E-A1BD-2A740D80302BQ52540247-0942A626-DE5D-4DDE-BC62-38F142BC16A0Q52597566-4015AD0B-BCDC-4F62-BC6C-6D0EF2B71452Q54942652-47658C5B-8590-4EDE-92F2-E641751E94BCQ56942176-099F7736-CA8C-44B9-9E6C-4F52A177A475Q58779206-38C6E3FF-EF29-4E02-817A-4D46DD6747AFQ58781085-AA6E2BE0-DD73-45D0-87E9-9FACABC52EE1
P2860
Neutrophils promote the malignant glioma phenotype through S100A4.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Neutrophils promote the malignant glioma phenotype through S100A4.
@ast
Neutrophils promote the malignant glioma phenotype through S100A4.
@en
type
label
Neutrophils promote the malignant glioma phenotype through S100A4.
@ast
Neutrophils promote the malignant glioma phenotype through S100A4.
@en
prefLabel
Neutrophils promote the malignant glioma phenotype through S100A4.
@ast
Neutrophils promote the malignant glioma phenotype through S100A4.
@en
P2093
P2860
P1476
Neutrophils promote the malignant glioma phenotype through S100A4
@en
P2093
John F de Groot
Lindsay Holmes
Ningyi Tiao
Verlene Henry
P2860
P304
P356
10.1158/1078-0432.CCR-13-1279
P407
P577
2013-11-15T00:00:00Z